http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3936720

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, Non-P.H.S.
endingPage 2271
issn 1476-5381
0007-1188
issueIdentifier 12
pageRange 2261-2271
publicationName British Journal of Pharmacology
startingPage 2261
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_05ab970b5813a76721243090ba9a4536
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fa692fa31ab7b0a951b395b4718a6684
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b747ca323d40435f47ae8047b9879c08
bibliographicCitation Yang Y, Adi T, Effraim PR, Chen L, Dib‐Hajj SD, Waxman SG. Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Nav1.7 mutation I234T. British J Pharmacology. 2017 Jul 30;175(12):2261–71. doi: 10.1111/bph.13935.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_863154fc18570ffe657b4c9d5d281d5c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5718-7177
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6417-3654
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3423-3318
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfdacde7a453fb87c2fc57f8434c2195
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_339cea94fb0c2722db405556541c08b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a48787fa1befb98d290e9492990e3f9
date 2017-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/bph.13935
https://pubmed.ncbi.nlm.nih.gov/28658526
https://pubmed.ncbi.nlm.nih.gov/PMC5980548
isPartOf https://portal.issn.org/resource/ISSN/1476-5381
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895
https://portal.issn.org/resource/ISSN/0007-1188
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Nav1.7 mutation I234T
discusses http://id.nlm.nih.gov/mesh/M0003328
http://id.nlm.nih.gov/mesh/M0568601
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D062556Q000235
http://id.nlm.nih.gov/mesh/D062556Q000378
http://id.nlm.nih.gov/mesh/D011984Q000187
http://id.nlm.nih.gov/mesh/D002220Q000494
http://id.nlm.nih.gov/mesh/D010597
http://id.nlm.nih.gov/mesh/D013696
http://id.nlm.nih.gov/mesh/D009154
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011984Q000378
http://id.nlm.nih.gov/mesh/D062556Q000737
http://id.nlm.nih.gov/mesh/D008958
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D057809
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8641
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b1f20ecb23efccb0a6662c6b19526cb0
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7642
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6997

Total number of triples: 53.